Theriva Biologics Insider Trades

SYN

Track insider trading activity from Theriva Biologics executives and directors. See which insiders are buying and selling SYN stock.

Trades Last 12 Months

SYN Price

All Insider Trades for Theriva Biologics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kraws Jeffrey J Director
Holding Value $112k 110,000 shares
Last Trade
Dec 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 110,000 shares
$1.02
$1.02
Holding Value $112k 110,000 shares
Last Trade
Dec 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 110,000 shares
$1.02
$1.02
Shallcross Steven A CEO And CFO
Holding Value $714k 700,000 shares
Last Trade
Dec 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$714k 700,000 shares
$1.02
$1.02
Monahan John J Director
Holding Value $112k 110,000 shares
Last Trade
Dec 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$112k 110,000 shares
$1.02
$1.02
Tufaro Francis Chief Operating Officer
Holding Value $102k 100,000 shares
Last Trade
Dec 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$102k 100,000 shares
$1.02
$1.02
Kirk Randal J 10% owner
Holding Value $169k 165,332 shares
Last Trade
Apr 03, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$621k 95,241 shares
$6.52
$1.02
Sliman Joseph A. Chief Medical Officer
Holding Value $418k 410,000 shares
Last Trade
Dec 20, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$74.6M 410,000 shares
$182.00
$1.02
Riley Jeffrey Scott Chief Executive Officer
Holding Value $1.15M 1,129,000 shares
Last Trade
Nov 30, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$315M 1,129,000 shares
$278.88
$1.02
Ballantyne Charles Evan Chief Financial Officer
Holding Value $204k 200,000 shares
Last Trade
Jan 08, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$108M 200,000 shares
$539.00
$1.02
Kanzer Steve H 10% owner
Holding Value $2.24M 2,195,489 shares
Last Trade
Apr 30, 2014 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.54B 5,003,025 shares
$507.50
$1.02
Stacks Nelson K. Director
Holding Value $0 0 shares
Last Trade
Feb 03, 2012 Sale
$57.5k 25,000 shares
$2.30
$1.02
Kuo James S Chairman, CEO & President
Holding Value $4.59k 4,500 shares
Last Trade
Aug 30, 2011 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.11k 4,500 shares
$0.69
$1.02
Lyon Lyman Max Jr CEO & President
Holding Value $0 0 shares
Last Trade
Dec 09, 2009 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$11.3k 25,000 shares
$0.45
$1.02
Stergis Nicholas Chief Executive Officer
Holding Value $816k 800,000 shares
Last Trade
Jul 08, 2008 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$576k 800,000 shares
$0.72
$1.02
Rudick A Joseph Director
Holding Value $58.4k 57,267 shares
Last Trade
Jan 29, 2008 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$51.8k 27,106 shares
$1.91
$1.02
Dorman Daniel J Director
Holding Value $0 0 shares
Last Trade
Nov 09, 2007 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$1.32M 247,542 shares
$5.35
$1.02
Holding Value $0 0 shares
Last Trade
Nov 09, 2007 Sale (In The Money)Reported as In The Money on SEC Form 4.
$3.31M 618,855 shares
$5.35
$1.02
Newsome David A. Chief Scientific Officer
Holding Value $153k 150,000 shares
Last Trade
Nov 02, 2007 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$878k 150,000 shares
$5.85
$1.02
Holding Value $111k 109,104 shares
Last Trade
Jul 16, 2007 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$46.4k 10,000 shares
$4.64
$1.02
Manion Michael F 10% owner, President
Holding Value $347k 340,000 shares
Last Trade
Nov 01, 2006 Purchase (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
No data
No data
$1.02

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up